Photo courtesy of: Getty / iStock
In July, Oregon Psilocybin Advisory Board members issued a report that reviewed many studies under psilocybin, required under Oregon’s historic voter-approved 2020 medical legalization initiative. Under a time-crunch, they are now working with a new psychedelic research center out of Harvard Law School to dive deeper on the matter.
As regulators prepare to license facilities to administer a legal psilocybin therapy program, an Oregon state panel has recently cleared a team of researchers to follow up with an in-depth report on the science, history, and culture of psilocybin.
The newly implemented research project is said to inform legislative efforts outside of Oregon, where psychedelic reform is still heavily considered. Mason Marks, who serves on the Oregon advisory board for psilocybin, recently mentioned this, “Given the increasing interest in psychedelics legislation, Oregon will likely be the first of several states to contemplate regulating psilocybin services.”
He continued, “To the extent that the report can help inform their decision making, it should be made available for that purpose.”
On a more positive note, Oregon’s initial review panel submitted a report that concluded psilocybin’s significant medical value for various health conditions. It’s also demonstrated to be “efficacious in reducing depression and anxiety, including in life-threatening conditions,” members found.
An upcoming review approved by the board will take up to six months to finalize. The new review is said to touch on smaller-scale notions like how psilocybin prohibition has “affected marginalized communities” and how the state’s law reform could impact them.
A simple breakthrough that's changing lives.
At least one of the gals is taking advantage of recreational cannabis.